Literature DB >> 9556096

Melatonin and human reproduction.

R J Reiter1.   

Abstract

In photoperiodic nonhuman mammals the secretion of melatonin from the pineal gland plays a major role in regulating reproductive physiology; in humans these relationships are less clear. The melatonin rhythm changes throughout life with the first substantial change in nocturnal melatonin secretion being reportedly associated with puberty. The transition from Tanner stage 1 to Tanner stage 5 of sexual maturation is associated with a significant reduction in nocturnal melatonin levels, but a cause-effect relationship has not been established. Menstrual cyclicity has been reported to be associated with fluctuations in melatonin production but whether they are related to, eg ovulation or menstruation is not established. At high latitudes the quantity of melatonin produced by the pineal gland varies with season (changes in the light-dark cycle), and there is some evidence that this changes reproductive efficiency accordingly. Menopause is associated with a reduction in melatonin which may relate to the changing gonadotropin levels. In males of the same age melatonin levels also drop with no significant alteration in reproductive physiology. While correlations between melatonin and the status of the reproductive system in humans have been noted, whether they are functionally related remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556096     DOI: 10.3109/07853899808999391

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  18 in total

1.  Long-Term stability of 6-hydroxymelatonin sulfate in 24-h urine samples stored at -20 degrees C.

Authors:  B Griefahn; T Remer; M Blaszkewicz; P Bröde
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

Review 2.  Light, blindness and endocrine secretions.

Authors:  A Bellastella; G Amato; A Bizzaro; C Carella; T Criscuolo; S Iorio; V I Muccitelli; G Pisano; A A Sinisi; A De Bellis
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

3.  Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro.

Authors:  Duo Wei; Cuilian Zhang; Culian Zhang; Juanke Xie; Xiaobing Song; Baoli Yin; Qi Liu; Lin Hu; Haoying Hao; Jiaxuan Geng; Peng Wang
Journal:  J Assist Reprod Genet       Date:  2013-06-06       Impact factor: 3.412

4.  Sun exposure, sexual behavior and uterine cervical human papilloma virus.

Authors:  William J M Hrushesky; Robert B Sothern; Wop J Rietveld; Jovelyn Du-Quiton; Mathilde E Boon
Journal:  Int J Biometeorol       Date:  2005-10-06       Impact factor: 3.787

5.  Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.

Authors:  L Potocki; D Glaze; D X Tan; S S Park; C D Kashork; L G Shaffer; R J Reiter; J R Lupski
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

Review 6.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

7.  Melatonin effects on metabolism independent of gonad function.

Authors:  Stephaney S Puchalski; Jill N Green; Dennis D Rasmussen
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

8.  Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion.

Authors:  Avi Rimler; Ralf Jockers; Zipora Lupowitz; Nava Zisapel
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Sleep, Melatonin, and the Menopausal Transition: What Are the Links?

Authors:  Shazia Jehan; Giardin Jean-Louis; Ferdinand Zizi; Evan Auguste; Seitikurippu R Pandi-Perumal; Ravi Gupta; Hrayr Attarian; Samy I McFarlane; Rüdiger Hardeland; Amnon Brzezinski
Journal:  Sleep Sci       Date:  2017 Jan-Mar

10.  Pronounced inflammatory response to endotoxaemia during nighttime: a randomised cross-over trial.

Authors:  Mahdi Alamili; Klaus Bendtzen; Jens Lykkesfeldt; Jacob Rosenberg; Ismail Gögenur
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.